Last reviewed · How we verify
NCT06163872
Doctors' Perspective on Tobacco Addiction
trial testing survey study in Nicotine Dependence in 941 participants. Completed in 30 September 2023.
30 July 2023
Quick facts
| Lead sponsor | Karadeniz Technical University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 941 |
| Start date | 1 May 2023 |
| Primary completion | 30 July 2023 |
| Estimated completion | 30 September 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- survey study
Conditions studied
- Nicotine Dependence — all drugs for Nicotine Dependence →
Sponsor
Karadeniz Technical University
Who can join
18 and older, any sex, with Nicotine Dependence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
ABSTRACT Aim: Our study aimed to determine the approaches of our physicians to the smoking habits of their patients other than those with pulmonary diseases. Method: Patients examined in different outpatient clinics of our hospital will be asked 7 questions about the doctor's approach to smoking habits. 1\) Do you have information about smoking cessation clinic? 2) Has your doctor asked if you smoke? 3) Did he suggest you stop using it? 4) Did he inform you about the relationship between smoking and your disease? 5) Did he provide information about smoking cessation outpatient clinic services? 6) Have you ever thought about quitting smoking after your doctor's briefing? 7) Did you quit smoking after your doctor's briefing?
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06163872
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of survey study
Trials testing the same drug.
- NCT07385196 — Defining Ileorectal Syndrome: a Prospective Observational Study · recruiting
- NCT06695364 — Opinions of NKU Faculty of Medicine Interns and Intern Doctors on Distance Medicine Education During the Covid-19 Pandem · NA · enrolling by invitation
- NCT04660357 — Osteoarthritis, Balance, and Fear of Falling · unknown
Other recruiting trials for Nicotine Dependence
Currently open trials in the same condition.
- NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
- NCT07250230 — Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Un · NA · recruiting
- NCT07040566 — A Trial of Varenicline for E-cigarette Cessation · Phase 2 · recruiting
- NCT07001930 — Effects of Cannabidiol on Stress and Nicotine Withdrawal · Phase 1 · recruiting
- NCT06765291 — Behavioral Intervention for Youth to Promote Vaping Cessation · NA · recruiting
Other Karadeniz Technical University trials
Trials by the same sponsor.
- NCT07526779 — Motivational Interviewing on Loneliness Level, Activities of Daily Living, and Quality of Life in Elderly · NA · not yet recruiting
- NCT07448168 — Effect of Standardized Patient Simulation on Nursing Students' Assessment, Diagnosis Skills, and Experiences · NA · not yet recruiting
- NCT07435233 — Different Reality Simulation Education Methods on Nursing Students · NA · active not recruiting
- NCT07238348 — Analgesic Effectiveness of SPSIPB Versus Thoracic Epidural and Systemic Opioid Analgesia After VATS (SPSIPB-VATS) · not yet recruiting
- NCT07297498 — The Effect of Simulation-based Education Within the Framework of the Clinical Judgment Model on Nursing Students' Clinic · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06163872 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karadeniz Technical University
- Last refreshed: 11 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06163872.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing